The relationship between different dimensions of alcohol use and the burden of disease-an update

Jürgen Rehm, Gerhard E Gmel Sr, Gerrit Gmel, Omer S M Hasan, Sameer Imtiaz, Svetlana Popova, Charlotte Probst, Michael Roerecke, Robin Room, Andriy V Samokhvalov, Kevin D Shield, Paul A Shuper, Jürgen Rehm, Gerhard E Gmel Sr, Gerrit Gmel, Omer S M Hasan, Sameer Imtiaz, Svetlana Popova, Charlotte Probst, Michael Roerecke, Robin Room, Andriy V Samokhvalov, Kevin D Shield, Paul A Shuper

Abstract

Background and aims: Alcohol use is a major contributor to injuries, mortality and the burden of disease. This review updates knowledge on risk relations between dimensions of alcohol use and health outcomes to be used in global and national Comparative Risk Assessments (CRAs).

Methods: Systematic review of reviews and meta-analyses on alcohol consumption and health outcomes attributable to alcohol use. For dimensions of exposure: volume of alcohol use, blood alcohol concentration and patterns of drinking, in particular heavy drinking occasions were studied. For liver cirrhosis, quality of alcohol was additionally considered. For all outcomes (mortality and/or morbidity): cause of death and disease/injury categories based on International Classification of Diseases (ICD) codes used in global CRAs; harm to others.

Results: In total, 255 reviews and meta-analyses were identified. Alcohol use was found to be linked causally to many disease and injury categories, with more than 40 ICD-10 three-digit categories being fully attributable to alcohol. Most partially attributable disease categories showed monotonic relationships with volume of alcohol use: the more alcohol consumed, the higher the risk of disease or death. Exceptions were ischaemic diseases and diabetes, with curvilinear relationships, and with beneficial effects of light to moderate drinking in people without heavy irregular drinking occasions. Biological pathways suggest an impact of heavy drinking occasions on additional diseases; however, the lack of medical epidemiological studies measuring this dimension of alcohol use precluded an in-depth analysis. For injuries, except suicide, blood alcohol concentration was the most important dimension of alcohol use. Alcohol use caused marked harm to others, which has not yet been researched sufficiently.

Conclusions: Research since 2010 confirms the importance of alcohol use as a risk factor for disease and injuries; for some health outcomes, more than one dimension of use needs to be considered. Epidemiological studies should include measurement of heavy drinking occasions in line with biological knowledge.

Keywords: Alcohol use; average volume; chronic disease; injury; patterns of drinking; risk-relations; systematic review; unrecorded consumption.

© 2017 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Figures

Figure 1
Figure 1
The impact of volume of alcohol use and heavy drinking upon major attributable disease outcomes.

References

    1. Rehm J., Imtiaz S. A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy 2016; 11: 37.
    1. Global Burden of Disease (GBD) 2015. Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1659–1724.
    1. Forouzanfar M. H., Alexander L., Anderson H. R., Bachman V. F., Biryukov S., Brauer M. et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 2287–2323.
    1. Lim S. S., Vos T., Flaxman A. D., Danaei G., Shibuya K., Adair‐Rohani H. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224–2260.
    1. Rehm J., Room R., Monteiro M., Gmel G., Graham K., Rehn N. et al. Alcohol use In: Ezzati M., Lopez A. D., Rodgers A., Murray C. J. L., editors. Comparative Quantification of Health Risks: Global and Regional Burden Of Disease Attributable To Selected Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004, pp. 959–1109.
    1. Ezzati M., Lopez A. D., Rodgers A. D., Vander Horn S., Murray C. J. L., Comparative Risk Assessment Collaborating Group Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360.
    1. Murray C. J. L., Lopez A. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997; 349: 1436–1442.
    1. World Health Organization . Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2014.
    1. World Health Organization . Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011.
    1. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009; 373: 2223–2233.
    1. Murray C. J. L., Ezzati M., Lopez A. D., Rodgers A., Vander Hoorn S. Comparative quantification of health risks: conceptual framework and methodological issues In: Ezzati M., Lopez A. D., Rodgers A., Murray C. J. L., editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004, pp. 1–38.
    1. Rehm J., Taylor B., Patra J., Gmel G. Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res 2006; 15: 181–191.
    1. Disease Control Priorities . About Disease Control Priorities, 3rd edn. University of Washington; 2016. Available at: /Web (accessed 11 October 2016) (Archived at ).
    1. Anderson P., Braddick F., Conrod P., Gual A., Hellman M., Matrai S. et al. The New Governance of Addictive Substances and Behaviours. Oxford, UK: Oxford University Press; 2017.
    1. Chisholm D., Rehm J., van Ommeren M., Monteiro M. Reducing the global burden of hazardous alcohol use: a comparative cost‐effectiveness analysis. J Stud Alcohol 2004; 65: 782–793.
    1. Chisholm D., Doran C., Shibuya K., Rehm J. Comparative cost‐effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev 2006; 25: 553–565.
    1. Medina‐Mora M. E., Monteiro M., Room R., Rehm J., Jernigan D., Sanchez‐Moreno D. et al. Alcohol Use and Alcohol Use Disorders In: Patel V., Chisholm D., Dua T., Laxminarayan R., Medina‐Mora M. E., editors. Mental, Neurological, and Substance Use Disorders. Washington, DC: The World Bank; 2015, pp. 127–144.
    1. Petersen I., Evans‐Lacko S., Semrau M., Barry M., Chisholm D., Gronholm P. et al. Population and community platform interventions In: Patel V., Chisholm D., Dua T., Laxminarayan R., Medina‐Mora M. E., editors. Mental, Neurological, and Substance Use Disorders. Washington, DC: The World Bank; 2015, pp. 183–200.
    1. Shidhaye R., Lund C., Chisholm D. Health care platform interventions In: Patel V., Chisholm D., Dua T., Laxminarayan R., Medina‐Mora M. E., editors. Mental, Neurological, and Substance Use Disorders. Washington, DC: The World Bank; 2015, pp. 201–218.
    1. Walter S. D. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829–849.
    1. Walter S. D. Prevention of multifactorial disease. Am J Epidemiol 1980; 112: 409–416.
    1. Rehm J., Kehoe T., Gmel G., Stinson F., Grant B., Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metrics 2010; 8: 3.
    1. Rehm J., Room R., Graham K., Monteiro M., Gmel G., Sempos C. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease—an overview. Addiction 2003; 98: 1209–1228.
    1. Rehm J., Baliunas D., Borges G. L., Graham K., Irving H. M., Kehoe T. et al. The relation between different dimensions of alcohol consumption and burden of disease—an overview. Addiction 2010; 105: 817–843.
    1. World Health Organization . International Statistical Classification of Diseases and Related Health Problems 10th Revision [internet]; 2016. Available at: /Web (accessed 12 October 2016) (Archived at ).
    1. Moher D., Liberati A., Tetzlaff J., Altman D. G., The Prisma Group Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: the PRISMA Statement. PLoS Med 2009; 6: e1000097.
    1. Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M. et al. Preferred Reporting Items for Systematic Review and Meta‐Analysis Protocols (PRISMA‐P) 2015 statement. Syst Rev 2015; 4: 1.
    1. Rothman K. J., Greenland S., Lash T. L. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
    1. Rehm J., Monteiro M., Room R., Gmel G., Jernigan D., Frick U. et al. Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res 2001; 7: 138–147.
    1. Hill A. B. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300.
    1. English D., Holman C., Milne E., Winter M., Hulse G., Codde G., et al. The Quantification of Drug Caused Morbidity and Mortality in Australia 1995. Canberra, Australia: Commonwealth Department of Human Services and Health; 1995.
    1. World Health Organization . International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva, Switzerland: World Health Organization; 2000.
    1. Institute for Health Metrics and Evaluation . Global Burden of Disease (GBD) [internet]; 2013. Available at: /Web (accessed 19 July 2016) (Archived at ).
    1. World Health Organization . Global Health Estimates (GHE) [internet]; 2016. Available at: Web (accessed 19 July 2016) (Archived at ).
    1. World Health Organization . Civil registration: why counting births and deaths is important [Internet]; 2014. Available at: Web (accessed 19 July 2016) (Archived at ).
    1. Murray C. J., Lozano R., Flaxman A. D., Serina P., Phillips D., Stewart A. et al. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med 2014; 12: 5.
    1. Rehm J., Mathers C. Global comparative risk assessment—what level of detail can be achieved? Lancet 2009; 374: 477.
    1. Goerdt A., Koplan J., Robine J., Thuriaux M., van Ginneken J. Non‐fatal health outcomes: Concepts, instruments and indicators In: Murray C., Lopez A., editors. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996, pp. 99–117.
    1. Rehm J., Hasan O. S. M., Imtiaz S., Neufield M. Quantifying the contribution of alcohol to cardiomyopathy: a systematic review. Alcohol 2017; in press.
    1. Rehm J., Anderson P., Gual A., Kraus L., Marmet S., Room R. et al. The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol 2014; 49: 118–122.
    1. Zaridze D., Lewington S., Boroda A., Scélo G., Karpov R., Lazarev A. et al. Alcohol and mortality in Russia: prospective observational study of 151,000 adults. Lancet 2014; 383: 1465–1473.
    1. Kessler R. C., Haro J. M., Heeringa S. G., Pennell B. E., Ustun T. B. The World Health Organization World Mental Health Survey Initiative. Epidemiol Psychiatr Soc 2006; 15: 161–166.
    1. Rehm J. How should prevalence of alcohol use disorders be assessed globally? Int J Methods Psychiatr Res 2016; 25: 79–85.
    1. Flaxman A. D., Vos T., Murray C. J. L. An Integrative Metaregression Framework for Descriptive Epidemiology. Washington, DC: University of Washington Press; 2015.
    1. National Institute on Alcohol Abuse and Alcoholism . Alcohol overdose: the dangers of drinking too much [internet]; 2015. Available at: /Web (accessed 7 November 2016) (Archived at ).
    1. Schomerus G., Lucht M., Holzinger A., Matschinger H., Carta M. G., Angermeyer M. C. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol 2011; 46: 105–112.
    1. Hudson P. The medical examiner looks at drinking In: Ewing J. A., Rouse B. A.,. e., editors. Drinking: Alcohol in American Society—Issues and Current Research. Chicago, IL: Nelson‐Hall; 1978, pp. 71–92.
    1. Zaridze D., Maximovitch D., Lazarev A., Igitov V., Boroda A., Boreham J. et al. Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol 2009; 38: 143–153.
    1. Rahu K., Palo E., Rahu M. Diminishing trend in alcohol poisoning mortality in Estonia: reality or coding peculiarity? Alcohol Alcohol 2011; 46: 485–489.
    1. Leon D. A., Shkolnikov V. M., McKee M., Kiryanov N., Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol 2010; 39: 1279–1290.
    1. Sidorenkov O., Nilssen O., Nieboer E., Kleshchinov N., Grijibovski A. M. Premature cardiovascular mortality and alcohol consumption before death in Arkhangelsk, Russia: an analysis of a consecutive series of forensic autopsies. Int J Epidemiol 2011; 40: 1519–1529.
    1. World Health Organization International Statistical Classification of Diseases and Related Health Problems, 10th revision, vol. 2. Instruction Manual. Geneva, Switzerland: World Health Organization; 2011.
    1. Lahti R. A., Vuori E. Fatal alcohol poisoning: medico‐legal practices and mortality statistics. Forensic Sci Int 2002; 126: 203–209.
    1. Landen M., Castle S., Nolte K., Gonzales M., Escobedo L., Chatterjee B. et al. Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in New Mexico. Am J Epidemiol 2003; 157: 273–278.
    1. Darke S. Heroin overdose. Addiction 2016; 111: 2060–2063.
    1. Lahti R. A., Sajantila A., Korpi H., Poikolainen K., Vuori E. Under‐recording of ethanol intoxication and poisoning in cause‐of‐death data: causes and consequences. Forensic Sci Int 2011; 212: 121–125.
    1. Popova S., Lange S., Shield K. D., Mihic A., Chudley A. E., Mukherjee R. A. S. et al. Co‐morbidity of Fetal Alcohol Spectrum Disorder: a systematic literature review and metaanalysis. Lancet 2016; 387: 978–987.
    1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Philadelphia, PA: American Psychiatric Association; 2013.
    1. May P. A., Blankenship J., Marais A.‐S., Gossage J. P., Kalberg W. O., Barnard R. et al. Approaching the prevalence of the full spectrum of fetal alcohol spectrum disorders in a South African population‐based study. Alcohol Clin Exp Res 2013; 37: 818–830.
    1. May P. A., de Vries M., Marais A.‐S., Buckley D., Kalberg W. O., Adnams C. M. et al. The continuum of fetal alcohol spectrum disorders in four rural communities in South Africa: prevalence and characteristics. Drug Alcohol Depend 2016; 159: 207–218.
    1. May P. A., Marais A.‐S., de Vries M. M., Kalberg W. O., Buckley D., Hasken J. M. et al. The continuum of fetal alcohol spectrum disorders in a community in South Africa: prevalence and characteristics in a fifth sample. Drug Alcohol Depend 2016; 168: 274–286.
    1. O'Leary‐Moore S. K., Parnell S. E., Lipinski R. J., Sulik K. K. Magnetic resonance‐based imaging in animal models of fetal alcohol spectrum disorder. Neuropsychol Rev 2011; 21: 167–185.
    1. Sulik K. K. Fetal alcohol spectrum disorder: pathogenesis and mechanisms. Handb Clin Neurol 2014; 125: 463–475.
    1. Hamilton D. A., Barto D., Rodriguez C. I., Magcalas C. M., Fink B. C., Rice J. P. et al. Effects of moderate prenatal alcohol exposure and age on social behavior, spatial response perseveration errors and motor behavior. Behav Brain Res 2014; 269: 44–54.
    1. Abel E. L. Fetal Alcohol Abuse Syndrome. New York: Plenum Press; 1998.
    1. Alvik A., Torgersen A. M., Aalen O. O., Lindermann R. Binge alcohol exposure once a week in early pregnancy predicts temperament and sleeping problems in the infant. Early Hum Dev 2011; 87: 827–833.
    1. Jacobson J. L., Jacobson S. W. Drinking moderately and pregnancy. Effects on child development. Alcohol Res Health 1999; 23: 25–30.
    1. Jones K. L., Smith D. W., Ulleland C. N., Streissguth A. P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973; 1: 1267–1271.
    1. Kelly Y., Sacker A., Gray R., Kelly J., Wolke D., Quigley M. A. Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age? Int J Epidemiol 2009; 38: 129–140.
    1. Sood B., Delaney‐Black V., Covington C., Nordstrom‐Klee B., Ager J., Templin T. et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose–response effect. Pediatrics 2001; 108: 1–9.
    1. Gray R., Henderson J. Review of the Fetal Effects of Prenatal Alcohol Exposure. Oxford, UK: University of Oxford; 2006.
    1. Linnet K. M., Dalsgaard S., Obel C., Wisborg K., Henriksen T. B., Rodriguez A. et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003; 160: 1028–1040.
    1. Testa M., Quigley B. M., Eiden R. D. The effects of prenatal alcohol exposure on infant mental development: a metaanalytical review. Alcohol Alcohol 2003; 38: 295–304.
    1. Popova S., Lange S., Probst C., Gmel G., Rehm J. Estimation of national, regional and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta‐analysis. Lancet Glob Health 2017; DOI: .
    1. Rehm J., Frick U. Valuation of health states in the U.S. study to establish disability weights: lessons from the literature. Int J Methods Psychiatr Res 2010; 19: 18–33.
    1. Salomon J. A., Haagsma J. A., Davis A., de Noordhout C. M., Polinder S., Havelaar A. H. et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 2015; 3: e712–e723.
    1. Szabo G., Saha B. Alcohol's effect on host defense. Alcohol Res 2015; 37: 159–170.
    1. Cook R. T. Alcohol abuse, alcoholism, and damage to the immune system—a review. Alcohol Clin Exp Res 1998; 22: 1927–1942.
    1. Zhang P., Bagby G. J., Happel K. I., Raasch C. E., Nelson S. Alcohol abuse, immunosuppression, and pulmonary infection. Curr Drug Abuse Rev 2008; 1: 56–67.
    1. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis 2005; 41: S490–S497.
    1. Boe D. M., Nelson S., Zhang P., Bagby G. J. Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae . J Infect Dis 2001; 184: 1134–1142.
    1. Szabo G., Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009; 33: 220–232.
    1. Goral J., Karavitis J., Kovacs E. J. Exposure‐dependent effects of ethanol on the innate immune system. Alcohol 2008; 42: 237–247.
    1. World Health Organization . Tuberculosis—fact sheet [internet]; 2016. Available at: Web (accessed 13 October 2016) (Archived at ).
    1. Rehm J., Samokhvalov A. V., Neuman M. G., Room R., Parry C. D., Lönnroth K. et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009; 9: 450.
    1. Lönnroth K., Williams B., Stadlin S., Jaramillo E., Dye C. Alcohol use as a risk factor for tuberculosis—a systematic review. BMC Public Health 2008; 8: 289.
    1. Imtiaz S., Roerecke M., Shield K. D., Samokhvalov A. V., Lönnroth K., Rehm J. Alcohol use, alcohol use dose and alcohol‐related problem as risk factors for tuberculosis: meta‐analyses and burden of disease. Toronto, ON: Centre for Addiction and Mental Health; 2016.
    1. Coker R., McKee M., Atun R., Dimitrova B., Dodonova E., Kuznetsov S. et al. Risk factors for pulmonary tuberculosis in Russia: case–control study. BMJ 2006; 332: 85–87.
    1. Rehm J., Marmet S., Anderson P., Gual A., Kraus L., Nutt D. J. et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol 2013; 48: 633–640.
    1. Rehm J., Gmel G. Patterns of alcohol consumption and social consequences. Results from an eight‐year follow‐up study in Switzerland. Addiction 1999; 94: 899–912.
    1. Hendershot C. S., Stoner S. A., Pantalone D. W., Simoni J. M. Alcohol use and antiretroviral adherence: review and meta‐analysis. J Acquir Immune Defic Syndr 2009; 52: 180–202.
    1. Gmel G., Shield K., Rehm J. Developing a methodology to derive alcohol‐attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication. Popul Health Metrics 2011; 9: 5.
    1. Hahn J. A., Woolf‐King S. E., Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in sub‐Saharan Africa. Curr HIV/AIDS Rep 2011; 8: 172–180.
    1. Fritz K., Morojele N., Kalichman S. Alcohol: the forgotten drug in HIV/AIDS. Lancet 2010; 376: 398–400.
    1. Rehm J., Parry C. D. Alcohol consumption and infectious diseases in South Africa. Lancet 2009; 374: 2053.
    1. Shuper P. A., Neuman M., Kanteres F., Baliunas D., Joharchi N., Rehm J. Causal considerations on alcohol and HIV/AIDS—a systematic review. Alcohol Alcohol 2010; 45: 159–166.
    1. Parry C. D. H., Rehm J. R., Poznyak V., Room R. Alcohol and infectious diseases: are there causal linkages? Addiction 2009; 104: 331–332.
    1. Rehm J., Probst C., Shield K. D., Shuper P. A. Does Alcohol Use Have a Causal Effect on HIV Incidence and Disease Progression? A Review of the Literature and a Modelling Strategy for Quantifying the Effect. Toronto, ON: Centre for Addiction and Mental Health; 2016.
    1. Williams E. C., Hahn J. A., Saitz R., Bryant K., Lira M. C., Samet J. H. Alcohol use and Human Immunodeficiency Virus (HIV) infection: Current knowledge, implications, and future directions. Alcohol Clin Exp Res 2016; 40: 2056–2072.
    1. Lan C. W., Scott‐Sheldon L. A., Carey K. B., Johnson B. T., Carey M. P. Prevalence of alcohol use, sexual risk behavior, and HIV among Russians in high‐risk settings: a systematic review and meta‐analysis. Int J Behav Med 2016; DOI: .
    1. Schensul J. J., Singh S. K., Gupta K., Bryant K., Verma R. Alcohol and HIV in India: a review of current research and intervention. AIDS Behav 2010; 14: S1–S7.
    1. Baliunas D., Rehm J., Irving H., Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta‐analysis. Int J Public Health 2010; 55: 159–166.
    1. Pithey A., Parry C. Descriptive systematic review of sub‐Saharan African studies on the association between alcohol use and HIV infection. SAHARA J 2009; 6: 155–169.
    1. Van H., Koblin B. A. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS 2009; 4: 314–318.
    1. Woolf S. E., Maisto S. A. Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav 2009; 13: 757–782.
    1. Fisher J. C., Bang H., Kapiga S. H. The association between HIV infection and alcohol use: a systematic review and meta‐analysis of African studies. Sex Transm Dis 2007; 34: 856–863.
    1. Steele C., Josephs R. Alcohol myopia: its prized and dangerous effects. Am Psychol 1990; 45: 921–933.
    1. Scott‐Sheldon L. A., Walstrom P., Carey K. B., Johnson B. T., Carey M. P. Alcohol use and sexual risk behaviors among individuals infected with HIV: a systematic review and meta‐analysis 2012 to early 2013. Curr HIV/AIDS Rep 2013; 10: 314–323.
    1. Woolf‐King S. E., Maisto S. A. Alcohol use and high‐risk sexual behavior in sub‐Saharan Africa: a narrative review. Arch Sex Behav 2011; 40: 17–42.
    1. Sales J. M., Brown J. L., Vissman A. T., DiClemente R. J. The association between alcohol use and sexual risk behaviors among African American women across three developmental periods: a review. Curr Drug Abuse Rev 2012; 5: 117–128.
    1. Kalichman S. C., Simbayi L. C., Kaufman M., Cain D., Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub‐Saharan Africa: systematic review of empirical findings. Prev Sci 2007; 8: 141–151.
    1. Shuper P. A., Joharchi N., Irving H., Rehm J. Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta‐analysis. AIDS Behav 2009; 13: 1021–1036.
    1. Scott‐Sheldon L. A., Carey K. B., Cunningham K., Johnson B. T., Carey M. P. Alcohol use predicts sexual decision‐making: a systematic review and meta‐analysis of the experimental literature. AIDS Behav 2016; 20 Suppl 1: S19–39.
    1. Rehm J., Shield K. D., Joharchi N., Shuper P. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta‐analysis of experimental studies. Addiction 2012; 107: 51–59.
    1. Shuper P. A., Joharchi N., Rehm J. Personality as a predictor of unprotected sexual behavior among people living with HIV/AIDS: a systematic review. AIDS Behav 2014; 18: 398–410.
    1. Shuper P. A., Joharchi N., Rehm J. Protocol for a controlled experiment to identify the causal role of acute alcohol consumption in condomless sex among HIV‐positive MSM: study procedures, ethical considerations, and implications for HIV prevention. AIDS Behav 2015; 20: 173–184.
    1. Cooper M. L. Alcohol use and risky sexual behavior among college students and youth. J Stud Alcohol 2002; 14: 101–117.
    1. Halpern‐Felsher B. L., Millstein S. G., Ellen J. M. Relationship of alcohol use and risky sexual behavior: a review and analysis of findings. J Adolesc Health 1996; 19: 331–336.
    1. Heath J., Lanoye A., Maisto S. A. The role of alcohol and substance use in risky sexual behavior among older men who have sex with men: a review and critique of the current literature. AIDS Behav 2011; 16: 578–589.
    1. Leigh B. C., Stall R. Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am Psychol 1993; 48: 1035–1045.
    1. Cook R. L., Clark D. B. Is there an association between alcohol consumption and sexually transmitted diseases? A systematic review. Sex Transm Dis 2005; 32: 156–164.
    1. Li Q., Stanton B. Alcohol use and sexual risk behaviors and outcomes in China: a literature review. AIDS Behav 2010; 14: 1227–1236.
    1. Sheeran P., Abraham C., Orbell S. Psychosocial correlates of heterosexual condom use: a meta‐analysis. Psychol Bull 1999; 125: 90–132.
    1. Sheeran P., Orbell S. Do intentions predict condom use? Meta‐analysis and examination of six moderator variables. Br J Soc Psychol 1998; 37: 231–250.
    1. Detels R., English P., Visscher B. R., Jacobson L., Kingsley L. A., Chmiel J. S. et al. Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr 1989; 2: 77–83.
    1. Pinkerton S. D., Abramson P. R. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44: 1303–1312.
    1. Smith D. K., Herbst J. H., Zhang X., Rose C. E. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2015; 68: 337–344.
    1. Pandrea I., Happel K. I., Amedee A., Bagby G. J., Nelson S. Alcohol's role in HIV transmission and disease progression. Alcohol Res Health 2010; 33: 203–218.
    1. Amedee A. M., Nichols W. A., Robichaux S., Bagby G. J., Nelson S. Chronic alcohol abuse and HIV disease progression: studies with the non‐human primate model. Curr HIV Res 2014; 12: 243–253.
    1. Hahn J. A., Samet J. H. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep 2010; 7: 226–233.
    1. Justice A. C., McGinnis K. A., Tate J. P., Braithwaite R. S., Bryant K. J., Cook R. L. et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend 2016; 161: 95–103.
    1. Bagby G. J., Amedee A. M., Siggins R. W., Molina P. E., Nelson S., Veazey R. S. Alcohol and HIV effects on the immune system. Alcohol Res 2015; 37: 287–297.
    1. Kumar S., Jin M., Ande A., Sinha N., Silverstein P. S., Kumar A. Alcohol consumption effect on antiretroviral therapy and HIV‐1 pathogenesis: role of cytochrome P450 isozymes. Expert Opin Drug Metab Toxicol 2012; 8: 1363–1375.
    1. Molina P. E., Amedee A. M., Winsauer P., Nelson S., Bagby G., Simon L. Behavioral, metabolic, and immune consequences of chronic alcohol or cannabinoids on HIV/AIDs: studies in the non‐human primate SIV model. J Neuroimmune Pharmacol 2015; 10: 217–232.
    1. Neuman M. G., Monteiro M., Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 2006; 41: 1395–1463.
    1. Neuman M. G., Schneider M., Nanau R. M., Parry C. HIV‐antiretroviral therapy induced liver, gastrointestinal, and pancreatic injury. Int J Hepatol 2012; 2012: 760706.
    1. Schneider M., Neuman M., Chersich M., Parry C. Alcohol and antiretroviral therapy—a lethal cocktail. J AIDS Clin Res 2011; S1: 005.
    1. Mehta A. J., Guidot D. M. Alcohol abuse, the alveolar macrophage and pneumonia. Am J Med Sci 2012; 343: 244–247.
    1. Siggins R. W., Melvan J. N., Welsh D. A., Bagby G. J., Nelson S., Zhang P. Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling. J Immunol 2011; 186: 4306–4313.
    1. Bhatty M., Pruett S. B., Swiatlo E., Nanduri B. Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol 2011; 45: 523–539.
    1. Rush B. An Inquiry Into the Effects of Ardent Spirits Upon the Human Body and Mind: With an Account of the Means of Preventing, and of the Remedies for Curing Them, 8th edn. Reprint. Exeter: NH: Richardson; 1785.
    1. Samokhvalov A. V., Irving H. M., Rehm J. Alcohol consumption as a risk factor for pneumonia: systematic review and meta‐analysis. Epidemiol Infect; 138: 1789–1795.
    1. Pflaum T., Hausler T., Baumung C., Ackermann S., Kuballa T., Rehm J. et al. Carcinogenic compounds in alcoholic beverages: an update. Arch Toxicol 2016; 90: 2349–2367.
    1. International Agency for Research on Cancer . Alcohol Drinking. Lyon, France: International Agency for Research on Cancer, World Health Organization; 1988.
    1. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency For Research On Cancer; 2010.
    1. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100E: Personal Habits and Indoor Combustions. Lyon, France: International Agency for Research on Cancer; 2012.
    1. World Cancer Research Fund International Continuous Update Project (CUP), WCRF International . Available at: /Web (accessed 21 October 2016) (Archived at ).
    1. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans [internet]; 2016. Available at: /Web (accessed 21 October 2016) (Archived at ).
    1. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Bouvard V. et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8: 292–293.
    1. Varela‐Rey M., Woodhoo A., Martinez‐Chantar M. L., Mato J. M., Lu S. C. Alcohol, DNA methylation, and cancer. Alcohol Res 2013; 35: 25.
    1. Shield K. D., Soerjomataram I., Rehm J. Alcohol use and breast cancer: a critical review. Alcohol Clin Exp Res 2016; 40: 1166–1181.
    1. Choi S. W., Frisco S. Interactions between folate and aging for carcinogenesis. Clin Chem Lab Med 2005; 43: 1151–1157.
    1. Cauley J. A., Lucas F. L., Kuller L. H., Stone K., Browner W., Cummings S. R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 1999; 130: 270–277.
    1. Key T. J., Appleby P. N., Reeves G. K., Travis R. C., Alberg A. J., Barricarte A. et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013; 14: 1009–1019.
    1. Hankinson S. E., Eliassen A. H. Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer 2010; 1: 2–10.
    1. Yu H., Berkel H. Do insulin‐like growth factors mediate the effect of alcohol on breast cancer risk? Med Hypotheses 1999; 52: 491–496.
    1. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 96—Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer; 2007.
    1. Talamini R., Bosetti C., La Vecchia C., Dal Maso L., Levi F., Bidoli E. et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control 2002; 13: 957–964.
    1. Park S. M., Lim M. K., Shin S. A., Yun Y. H. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006; 24: 5017–5024.
    1. Lee J. E., Hunter D. J., Spiegelman D., Adami H. O., Albanes D., Bernstein L. et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst 2007; 99: 801–810.
    1. Chow W. H., Dong L. M., Devesa S. S. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7: 245–257.
    1. Zhang G. M., Zhu Y., Ye D. W. Metabolic syndrome and renal cell carcinoma. World J Surg Oncol 2014; 12: 236.
    1. World Cancer Research Fund (WRCF). International, American Institute for Cancer Research . Continuous Update Project report: Food, Nutrition, Physical Activity, and Kidney Cancer. London, UK: WRCF International; 2015.
    1. Langcake P., Pryce R. J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Path 1976; 9: 77–86.
    1. Baur J. A., Mai A. Revelations into resveratrol's mechanism. Nat Med 2012; 18: 500–501.
    1. Siemann E. H., Creasy L. L. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43: 49–52.
    1. Kraft T. E., Parisotto D., Schempp C., Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 2009; 49: 782–799.
    1. Lachenmeier D. W., Godelmann R., Witt B., Riedel K., Rehm J. Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose–response assessment. Int J Cancer 2014; 134: 144–153.
    1. Bagnardi V., Rota M., Botteri E., Tramacere I., Islami F., Fedirko V. et al. Alcohol consumption and site‐specific cancer risk: a comprehensive dose–response meta‐analysis. Br J Cancer 2015; 112: 580–593.
    1. Corrao G., Bagnardi V., Zambon A., La Vecchia C. A meta‐analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613–619.
    1. Scoccianti C., Straif K., Romieu I. Recent evidence on alcohol and cancer epidemiology. Future Oncol 2013; 9: 1315–1322.
    1. Fillmore K. M., Kerr W. C., Stockwell T., Chikritzhs T., Bostrom A. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Addict Res Theory 2006; 14: 101–132.
    1. Rehm J., Irving H., Ye Y., Kerr W. C., Bond J., Greenfield T. K. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol 2008; 168: 866–871.
    1. Zeisser C., Stockwell T. R., Chikritzhs T. Methodological biases in estimating the relationship between alcohol consumption and breast cancer: the role of drinker misclassification errors in meta‐analytic results. Alcohol Clin Exp Res 2014; 38: 2297–2306.
    1. Roerecke M., Shield K. D., Higuchi S., Yoshimura A., Larsen E., Rehm M. X. et al. Estimates of alcohol‐related oesophageal cancer burden in Japan: systematic review and meta‐analyses. Bull World Health Organ 2015; 93: 329–338.
    1. Shield K. D., Parry C., Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res 2013; 35: 155–171.
    1. Rehm J. Light or moderate drinking is linked to alcohol related cancers, including breast cancer. BMJ 2015; 351: h4400.
    1. Shield K. D., Rylett M., Rehm J. Public health successes and missed opportunities In: Trends in Alcohol Consumption and Attributable Mortality in the WHO European Region, 1990–2014. Copenhagen, Denmark: WHO European Region; 2016.
    1. Bagnardi V., Rota M., Botteri E., Tramacere I., Islami F., Fedirko V. et al. Light alcohol drinking and cancer: a meta‐analysis. Ann Oncol 2013; 24: 301–308.
    1. Chen W. Y., Rosner B., Hankinson S. E., Colditz G. A., Willett W. C. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 2011; 306: 1884–1890.
    1. Brooks P. J., Enoch M. A., Goldman D., Li T. K., Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLOS Med 2009; 6: 258–263.
    1. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7: 149–156.
    1. Yokoyama A., Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Alcohol 2005; 35: 175–185.
    1. Praud D., Rota M., Rehm J., Shield K., Zatonski W., Hashibe M. et al. Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer 2016; 138: 1380–1387.
    1. Holmes J., Meier P. S., Booth A., Guo Y., Brennan A. The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend 2012; 123: 7–14.
    1. Rehm J., Patra J., Popova L. Alcohol drinking cessation and its effect on oesophageal and head and neck cancers: a pooled analysis. Int J Cancer 2007; 121: 1132–1137.
    1. Kontis V., Mathers C. D., Rehm J., Stevens G. A., Shield K. D., Bonita R. et al. Contribution of six risk factors to achieving the ‘25 × 25’ NCD mortality reduction target. Lancet 2014; 384: 427–437.
    1. Howard A. A., Arnsten J. H., Gourevitch M. N. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 2004; 140: 211–219.
    1. Koppes L. L. J., Bouter L. M., Dekker J. M., Heine R. J., Hendricks H. F. J. Moderate alcohol consumption lowers the risk of type 2 diabetes. A meta‐analysis of prospective observational studies. Diabetes Care 2005; 28: 719–725.
    1. Carlsson S., Hammar N., Grill V. Alcohol consumption and type 2 diabetes meta‐analysis of epidemiological studies indicates a U‐shaped relationship. Diabetologia 2005; 48: 1051–1054.
    1. Baliunas D., Taylor B., Irving H., Roerecke M., Patra J., Mohapatra S. et al. Alcohol as a risk factor for type 2 diabetes—a systematic review and meta‐analysis. Diabetes Care 2009; 32: 2123–2132.
    1. Knott C., Bell S., Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose–response meta‐analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care 2015; 38: 1804–1812.
    1. Li X. H., Yu F. F., Zhou Y. H., He J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose–response meta‐analysis. Am J Clin Nutr 2016; 103: 818–829.
    1. Schrieks I. C., Heil A. L., Hendriks H. F., Mukamal K. J., Beulens J. W. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta‐analysis of intervention studies. Diabetes Care 2015; 38: 723–732.
    1. Hirst J. A., Aronson J. K., Feakins B. G., Ma C., Farmer A. J., Stevens R. J. Short‐ and medium‐term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta‐analysis of randomized trials. Diabet Med 2016; DOI: .
    1. Heianza Y., Arase Y., Saito K., Tsuji H., Fujihara K., Hsieh S. D. et al. Role of alcohol drinking pattern in type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 11 (TOPICS 11). Am J Clin Nutr 2013; 97: 561–568.
    1. Vaeth P. A., Caetano R., Durazo E. M. Ethnicity and alcohol consumption among US adults with diabetes. Ann Epidemiol 2014; 24: 720–726.
    1. Babor T., Rehm J., Jernigan D., Vaeth P., Monteiro M., Lehman H. Alcohol, diabetes and public health interventions in the Americas. Rev Panam Salud Publ/Pan Am J Public Health 2012; 32: 151–155.
    1. Global Burden of Disease (GBD) DALYs and HALE Collaborators (2016). Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2015; 388: 1603–1658.
    1. Global Burden of Disease (GBD) Mortality and Causes of Death Collaborators (2016). Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2015; 388: 1459–1544.
    1. Letenneur L. Moderate alcohol consumption and risk of developing dementia in the elderly: the contribution of propsective studies. Ann Epidemiol 2007; 17: S43–5.
    1. Peters R., Peters J., Warner J., Beckett N., Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008; 37: 505–512.
    1. Anstey K. J., Mack H. A., Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta‐analysis of prospective studies. Am J Geriatr Psychiatry 2009; 17: 542–555.
    1. Di Marco L. Y., Marzo A., Muñoz‐Ruiz M., Ikram M. A., Kivipelto M., Ruefenacht D. et al. Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies. J Alzheimers Dis 2014; 42: 119–135.
    1. Lafortune L., Martin S., Kelly S., Kuhn I., Remes O., Cowan A. et al. Behavioural risk factors in mid‐life associated with successful ageing, disability, dementia and frailty in later life: a rapid systematic review. PLoS One 2016; 11: e0144405.
    1. Gupta S., Warner J. Alcohol‐related dementia: a 21st‐century silent epidemic? Br J Psychiatry 2008; 193: 351–353.
    1. Beydoun M. A., Beydoun H. A., Gamaldo A. A., Teel A., Zonderman A. B., Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta‐analysis. BMC Public Health 2014; 24: 643.
    1. Cooper C., Sommerlad A., Lyketsos C. G., Livingston G. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta‐analysis. Am J Psychiatry 2015; 172: 323–334.
    1. Kumari M., Holmes M. V., Dale C. E., Hubacek J. A., Palmer T. M., Pikhart H. et al. Alcohol consumption and cognitive performance: a Mendelian randomization study. Addiction 2014; 109: 1462–1471.
    1. Ridley N. J., Draper B., Withall A. Alcohol‐related dementia: an update of the evidence. Alzheimers Res Ther 2013; 5: 3.
    1. Daulatzai M. A. ‘Boomerang neuropathology’ of late‐onset Alzheimer's disease is shrouded in harmful ‘BDDS’: breathing, diet, drinking, and sleep during aging. Neurotox Res 2015; 28: 55–93.
    1. Collins M. A., Neafsey E. J., Mukamal K. J., Gray M. O., Parks D. A., Das D. K. et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009; 33: 206–219.
    1. Piazza‐Gardner A. K., Faffud T. J., Barry A. E. The impact of alcohol on Alzheimer's disease: a systematic review. Aging Ment Health 2013; 17: 133–146.
    1. Sullivan L. E., Fiellin D. A., O'Connor P. G. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med 2005; 118: 330–341.
    1. Kessler R. C., Crum R. M., Warner L. A., Nelson C. B., Schulenberg J., Anthony J. C. Lifetime co‐occurrence of DSM‐III‐R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–321.
    1. Regier D., Farmer M., Rae D., Locke B., Keith S., Judd L. et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990; 264: 2511–2518.
    1. Helzer J. E., Pryzbeck T. R. The co‐occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988; 49: 219–224.
    1. World Health Organization . Alcohol dependence with alcohol‐induced mood disorder ‐ F10.24 [internet]; 2016. Available at: Web (accessed 31 October 2016) (Archived at ).
    1. Boden J. M., Fergusson D. M. Alcohol and depression. Addiction 2011; 106: 906–914.
    1. Bolton J. M., Robinson J., Sareen J. Self‐medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 2009; 115: 367–375.
    1. Fergusson D. M., Boden J. M., Horwood L. J. Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry 2009; 66: 260–266.
    1. Falk D. E., Yi H. Y., Hilton M. E. Age of onset and temporal sequencing of lifetime DSM‐IV alcohol use disorders relative to comorbid mood and anxiety disorders. Drug Alcohol Depend 2008; 94: 234–245.
    1. Haynes J. C., Farrell M., Singleton N., Meltzer H., Araya R., Lewis G. et al. Alcohol consumption as a risk factor for anxiety and depression. Br J Psychiatry 2005; 187: 544–551.
    1. Samokhvalov A. V., Farid A. K., Selby P., Rehm J. Alcohol‐related seizure disorders In: Reuber M., Schachter S. C., editors. Borderland of Epilepsy Revisited. New York, NY: Oxford University Press; 2012, pp. 144–154.
    1. Bartolomei F., Suchet L., Barrie M., Gastaut J. L. Alcoholic epilepsy: a unified and dynamic classification. Eur Neurol 1997; 37: 13–17.
    1. Hattemer K., Knake S., Oertel W. H., Hamer H. M., Rosenow F. Recurrent alcohol‐induced seizures in a patient with chronic alcohol abuse. Epileptic Disord 2008; 10: 162–164.
    1. Hillbom M., Pieninkeroinen I., Leone M. Seizures in alcohol‐dependent patients: epidemiology, pathophysiology and management. CNS Drugs 2003; 17: 1013–1030.
    1. Devetag F., Mandich G., Zaiotti G., Toffolo G. G. Alcoholic epilepsy: review of series and and proposed classification and etiopathogenesis. Ital J Neurol Sci 1983; 4: 275–284.
    1. Fisher R. S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P. et al. Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 2005; 46: 470–472.
    1. Samokhvalov A. V., Irving H., Mohapatra S., Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: a systematic review and meta‐analysis. Epilepsia 2010; 51: 1177–1184.
    1. Ballenger J. C., Post R. M. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 1978; 133: 1–14.
    1. Gonzalez L. P., Veatch L. M., Ticku M. K., Becker H. C. Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcohol Clin Exp Res 2001; 25: 197s–201s.
    1. Dam A. M., Fuglsang‐Frederikse A., Svarre‐Olsen U., Dam M. Late‐onset epilepsy: etiologies, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan. Epilepsia 1985; 26: 227–231.
    1. Freedland E. S., McMicken D. B. Alcohol‐related seizures, part I: pathophysiology, differencial diagnosis and evaluation. J Emerg Med 1993; 11: 463–473.
    1. Rathlev N. K., Ulrich A. S., Delanty N., D'Onofrio D., D'Onofrio G. Alcohol‐related seizures. J Emerg Med 2006; 31: 157–163.
    1. Barclay G. A., Barvour J., Stewart S., Day C. P., Gilvarry E. Adverse physical effects of alcohol misuse. Adv Psychiatr Treat 2008; 14: 139–151.
    1. Leach J. P., Mohanraj R., Borland W. Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention. Epilepsia 2012; 53: 48–57.
    1. Roerecke M., Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep 2012; 14: 556–562.
    1. O'Keefe J. H., Bhatti S. K., Bajwa A., DiNicolantonio J. J., Lavie C. J. Alcohol and cardiovascular health: the dose makes the poison... or the remedy. Mayo Clin Proc 2014; 89: 382–393.
    1. Klatsky A. L. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med 2015; 278: 238–250.
    1. Taylor B., Irving H. M., Baliunas D., Roerecke M., Patra J., Mohapatra S. et al. Alcohol and hypertension: gender differences in dose–response relationships determined through systematic review and meta‐analysis. Addiction 2009; 104: 1981–1990.
    1. Briasoulis A., Agarwal V., Messerli F. H. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta‐analysis. J Clin Hypertension 2012; 14: 792–798.
    1. Roerecke M., Rehm J. Chronic heavy drinking and ischaemic heart disease: a systematic review and meta‐analysis. Open Heart 2014; 1: e000135.
    1. Iacovoni A., De Maria R., Gavazzi A. Alcoholic cardiomyopathy. J Cardiovasc Med 2010; 11: 884–892.
    1. Kodama S., Saito K., Tanaka S., Horikawa C., Saito A., Heianza Y. et al. Alcohol consumption and risk of atrial fibrillation: a meta‐analysis. J Am Coll Cardiol 2011; 57: 427–436.
    1. Patra J., Taylor B., Irving H., Roerecke M., Baliunas D., Mohapatra S. et al. Alcohol consumption and the risk of morbidity and mortality from different stroke types—a systematic review and meta‐analysis. BMC Public Health 2010; 10: 258.
    1. Roerecke M., Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta‐analysis. Am J Epidemiol 2010; 171: 633–644.
    1. Roerecke M., Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta‐analyses and a systematic review and meta‐analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 2014; 12: 182.
    1. Leong D. P., Smyth A., Teo K. K., McKee M., Rangarajan S., Pais P. et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study. Circulation 2014; 130: 390–398.
    1. Guiraud V., Amor M. B., Mas J. L., Touzé E. Triggers of ischemic stroke: a systematic review. Stroke 2010; 41: 2669–2677.
    1. O'Donnell M. J., Chin S. L., Rangarajan S., Xavier D., Liu L., Zhang H. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case–control study. Lancet 2016; 388: 761–775.
    1. Mostofsky E., Chahal H. S., Mukamal K. J., Rimm E. B., Mittleman M. A. Alcohol and immediate risk of cardiovascular events: a systematic review and dose–response meta‐analysis. Circulation 2016; 133: 979–987.
    1. McKee M., Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med 1998; 91: 402–407.
    1. Tonelo D., Providência R., Gonçalves L. Holiday heart syndrome revisited after 34 years. Arq Bras Cardiol 2013; 101: 183–189.
    1. Puddey I. B., Rakic V., Dimmitt S. B., Beilin L. J. Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors—a review. Addiction 1999; 94: 649–663.
    1. Ronksley P. E., Brien S. E., Turner B. J., Mukamal K. J., Ghali W. A. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta‐analysis. BMJ 2011; 342: d671.
    1. Roerecke M., Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta‐analysis. Addiction 2012; 107: 1246–1260.
    1. Stockwell T., Greer A., Fillmore K., Chikritzhs T., Zeisser C. How good is the science. BMJ 2012; 344: e2276.
    1. Holmes M. V., Dale C. E., Zuccolo L., Silverwood R. J., Guo Y., Ye Z. et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014; 349: g4164.
    1. Emberson J. R., Bennett D. A. Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both? Vasc Health Risk Manag 2006; 2: 239–249.
    1. Rehm J., Sempos C., Trevisan M. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease—a review. J Cardiovasc Risk 2003; 10: 15–20.
    1. Brien S. E., Ronksley P. E., Turner B. J., Mukamal K. J., Ghali W. A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta‐analysis of interventional studies. BMJ 2011; 342: d636.
    1. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 2004; 364: 937–952.
    1. Roy A., Prabhakaran D., Jeemon P., Thankappan K. R., Mohan V., Ramakrishnan L. et al. Impact of alcohol on coronary heart disease in Indian men. Atherosclerosis 2010; 210: 531–535.
    1. Tolstrup J. S., Wium‐Andersen M. K., Ørsted D. D., Nordestaard B. G. Alcohol consumption and risk of atrial fibrillation: Observational and genetic estimates of association. Eur J Prev Cardiol 2016; 23: 1514–1523.
    1. Frick U., Rehm J. Can we establish causality with statistical analyses? The example of epidemiology In: Wiedermann W., von Eye A., editors. Statistics and Causality: Methods for Applied Empirical Research. Hoboken, NJ: Wiley; 2016, pp. 407–432.
    1. Kehoe T., Gmel G. Jr., Shield K., Gmel G. Sr., Rehm J. Determining the best population‐level alcohol consumption model and its impact on estimates of alcohol‐attributable harms. Popul Health Metrics 2012; 10: 6.
    1. Rehm J., Shield K. D., Roerecke M., Gmel G. Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health 2016; 16: 363.
    1. Shield K., Rehm J. Russia‐specific relative risks and their effects on the estimated alcohol‐attributable burden of disease. BMC Public Health 2015; 15: 482.
    1. Zaridze D., Brennan P., Boreham J., Boroda A., Karpov R., Lazarev A. et al. Alcohol and cause‐specific mortality in Russia: a retrospective case–control study of 48,557 adult deaths. Lancet 2009; 373: 2201–2214.
    1. Malyutina S., Bobak M., Kurilovitch S., Ryizova E., Nikitin Y., Marmot M. Alcohol consumption and binge drinking in Novosibirsk, Russia, 1985–95. Addiction 2001; 96: 987–995.
    1. Bobak M., Room R., Pikhart H., Kubinova S., Malyutina S., Pajak A. et al. Contribution of drinking patterns to differences in rates of alcohol related problems between three urban populations. J Epidemiol Community Health 2004; 58: 238–248.
    1. Rehm J. What can we learn from Russia about alcohol epidemiology and alcohol policy? Lancet 2014; 383: 1440–1442.
    1. Shield K. D., Rylett M., Rehm J. Public health gains and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990–2014: a report to the WHO European Region, Toronto, Canada: Centre for Addiction and Mental Health; 2016.
    1. Britton A., McKee M. The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J Epidemiol Community Health 2000; 54: 328–332.
    1. Lopez A. D., Williams T. N., Levin A., Tonelli M., Singh J. A., Burney P. G. J. et al. Remembering the forgotten non‐communicable diseases. BMC Med 2014; 12: 200.
    1. Rehm J., Samokhvalov A. V., Shield K. D. Global burden of alcoholic liver diseases. J Hepatol 2013; 59: 160–168.
    1. European Association for the Study of the Liver (EASL) . EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: j399–j420.
    1. Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572–1585.
    1. Rehm J., Taylor B., Mohapatra S., Irving H., Baliunas D., Patra J. et al. Alcohol as a risk factor for liver cirrhosis ‐ a systematic review and meta‐analysis. Drug Alcohol Rev 2010; 29: 437–445.
    1. Mokdad A. A., Lopez A. D., Shahraz S., Lozano R., Mokdad A. H., Stanaway J. et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014; 12: 145.
    1. Lelbach W. K. Epidemiology of alcoholic liver disease. Prog Liver Dis 1976; 5: 515.
    1. Rehm J., Roerecke M. Patterns of drinking and liver cirrhosis—what do we know and where do we go? J Hepatol 2015; 62: 1061–1067.
    1. Marugame T., Yamamoto S., Yoshimi I., Sobue T., Inoue M., Tsugane S. Patterns of alcohol drinking and all‐cause mortality: results from a large‐scale population‐based cohort study in Japan. Am J Epidemiol 2007; 165: 1039–1046.
    1. Askgaard G., Grønbæk M., Kjaer M. S., Tjønneland A., Tolstrup J. S. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol 2015; 62: 106–107.current issue
    1. Szücs S., Sarvary A., McKee M., Adany R. Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation. Addiction 2005; 100: 536–542.
    1. Lachenmeier D. W., Gmel G., Rehm J. Unrecorded alcohol consumption In: Boyle P., Boffetta P., Lowenfels A. B. et al., editors. Alcohol: Science, Policy, and Public Health. Oxford, UK: Oxford University Press; 2013, pp. 132–142.
    1. Leitz J., Kuballa T., Rehm J., Lachenmeier D. W. Chemical analysis and risk assessment of Diethyl Phthalate in alcoholic beverages with special regard to unrecorded alcohol. PLoS One 2009; 4: e8127.
    1. Solodun Y. V., Monakhova Y. B., Kuballa T., Samokhvalov A. V., Rehm J., Lachenmeier D. W. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol 2011; 4: 198–205.
    1. Rehm J., Kanteres F., Lachenmeier D. W. Unrecorded consumption, quality of alcohol and health consequences. Drug Alcohol Rev 2010; 29: 426–436.
    1. Lachenmeier D. W., Monakhova Y. B., Rehm J. Influence of unrecorded alcohol consumption on liver cirrhosis mortality. World J Gastroenterol 2014; 20: 7217–7222.
    1. Rehm J., Kailasapillai S., Larsen E., Rehm M. X., Samokhvalov A. V., Shield K. D. et al. A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction 2014; 109: 880–893.
    1. Puffer R. R., Griffith G. W. Patterns of Urban Mortality: Report of the Inter‐American Investigation of Mortality. Washington, DC: Pan American Health Organization; 1967.
    1. Prytz H., Anderson H. Underreporting of alcohol‐related mortality from cirrhosis is declining in Sweden and Denmark. Scand J Gastroenterol 1988; 23: 1035–1043.
    1. Haberman P. W., Weinbaum D. F. Liver cirrhosis with and without mention of alcohol as cause of death. Br J Addict 1990; 85: 217–222.
    1. Tuusov J., Lang K., Väli M., Pärna K., Tõnisson M., Ringmets I. et al. Prevalence of alcohol‐related pathologies at autopsy: Estonian forensic study of alcohol and premature death. Addiction 2014; 109: 2018–2026.
    1. Pollock D. A., Boyle C. A., DeStefano F., Moyer L. A., Kirk M. L. Underreporting of alcohol‐related mortality on death certificates of young U.S. army veterans. JAMA 1987; 258: 345–348.
    1. Yadav D., Hawes R. H., Brand R. E., Anderson M. A., Money M. E., Banks P. A. et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169: 1035–1045.
    1. Braganza J., Lee S., McCloy R., McMahon M. Chronic pancreatitis. Lancet 2011; 377: 1184–1197.
    1. Yadav D., Lowenfels A. B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252–1261.
    1. Lankisch P., Apte M., Banks P. Acute pancreatitis. Lancet 2015; 386: 85–96.
    1. Majumder S., Chari S. T. Chronic pancreatitis. Lancet 2016; 387: 1957–1966.
    1. Sankaran S. J., Xiao A. Y., Wu L. M., Windsor J. A., Forsmark C. E., Petrov M. S. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta‐analysis. Gastroenterology 2015; 149: 1490–1500.
    1. Gonzalez F. J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005; 569: 101–110.
    1. Pandol S. J., Raraty M. Pathobiology of alcoholic pancreatitis. Pancreatology 2007; 7: 105–114.
    1. Witt H., Apte M. V., Keim V., Wilson J. S. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007; 132: 1557–1573.
    1. Gerasimenko J. V., Gerasimenko O. V., Petersen O. H. The role of Ca(2+) in the pathophysiology of pancreatitis. J Physiol 2014; 592: 269–280.
    1. Irving H. M., Samokhvalov A., Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta‐analysis. J Pancreas 2009; 10: 387–392.
    1. Samokhvalov A. V., Rehm J., Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta‐analyses. EBioMedicine 2015; 2: 1996–2002.
    1. Eckardt M., File S., Gessa G., Grant K., Guerri C., Hoffman P. et al. Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 1998; 22: 998–1040.
    1. Cherpitel C., Ye Y., Bond J., Borges G., Autonoma M., Monteiro M. et al. Alcohol attributable fraction for injury morbidity from the dose–response relationship of acute alcohol consumption: emergency department data from 18 countries. Addiction 2015; 110: 1724–1732.
    1. Taylor B., Irving H. M., Kanteres F., Room R., Borges G., Cherpitel C. et al. The more you drink, the harder you fall: a systematic review and meta‐analysis of how acute alcohol consumption and injury or collision risk increase together. Drug Alcohol Depend 2010; 110: 108–116.
    1. Taylor B., Rehm J. The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol Clin Exp Res 2012; 36: 1827–1834.
    1. Krüger H. P., Kazenwadel J., Vollrath M. Grand Rapids effects revisited: accidents, alcohol and risk In: Kloeden C. N., McLean A. J., editors. Alcohol, Drugs, and Traffic Safety: Proceedings of the 13th International Conference on Alcohol, Drugs and Traffic Safety, Adelaide. Adelaide: NHMRC Road Accident Research Unit, University of Adelaide; 1995, pp. 222–230.
    1. Rehm J. Commentary on Cherpitel et al. (2015): improving global estimates of alcohol‐attributable injury. Addiction 2015; 110: 1733–1734.
    1. Rafia R., Brennan A. Modelling methods to estimate the potential impact of lowering the blood alcohol concentration limit from 80 mg/100 ml to 50 mg/100 ml in England and Wales: Report to the National Institute for Health and Clinical Excellence [Internet]. The University of Sheffield; 2010. Available at: /Web (accessed 3 November 2016) (Archived at ).
    1. Darvishi N., Farhadi M., Haghtalab T., Poorolajal J. Alcohol‐related risk of suicidal ideation, suicide attempt, and completed suicide: a meta‐analysis. PLoS One 2015; 10: e0126870.
    1. Norström T., Rossow I. Alcohol consumption as a risk factor for suicidal behavior: a systematic review of associations at the individual and at the population level. Arch Suicide Res 2016; 20: 489–506.
    1. Cherpitel C. J., Borges G. L., Wilcox H. C. Acute alcohol use and suicidal behavior: a review of the literature. Alcohol Clin Exp Res 2004; 28: 18S–28S.
    1. Borges G., Loera C. R. Alcohol and drug use in suicidal behaviour. Curr Opin Psychiatry 2010; 23: 195–204.
    1. Taylor B., Shield K., Rehm J. Combining best evidence: a novel method to calculate the alcohol‐attributable fraction and its variance for injury mortality. BMC Public Health 2011; 11: 265.
    1. Shield K. D., Gmel G. Jr., Patra J., Rehm J. Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption. Popul Health Metrics 2012; 10: 9.
    1. Haagsma J. A., Graetz N., Bolliger I., Naghavi M., Higashi H., Mullany E. C. et al. The global burden of injury: incidence, mortality, disability‐adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev 2016; 22: 3–18.
    1. Gmel G., Rehm J., Frick U. Trinkmuster, Pro‐Kopf‐Konsum von Alkohol und koronare Mortalitat [Drinking patterns, per capita consumption of alcohol and coronary mortality]. Sucht 2003; 49: 95–104.
    1. Hemström Ö. Per capita alcohol consumption and ischaemic heart disease mortality. Addiction 2001; 96: S93–S112.
    1. Pun V. C., Lin H., Kim J. H., Yip B. H., Chung V. C., Wong M. C. et al. Impacts of alcohol duty reductions on cardiovascular mortality among elderly Chinese: a 10‐year timeseries analysis. J Epidemiol Community Health 2013; 67: 514–518.
    1. Morgenstern H. Ecological studies In: Rothman K., Greenland S., Lash T., editors. Modern Epidemiology, 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2008, pp. 511–531.
    1. Gell L., Ally A., Buykx P., Hope A., Meier P. Alcohol's Harm to others: An Institute of Alcohol Studies report. London, UK: Institute of Alcohol Studies; 2015.
    1. Laslett A. M., Catalano P., Chikritzhs T., Dale C., Doran C., Ferris J. et al. The Range and Magnitude of Alcohol's Harm to Others. Fitzroy, Australia: Turning Point Alcohol and Drug Centre; 2010.
    1. Laslett A. M., Room R., Ferris J., Wilkinson C., Livingston M., Mugavin J. Surveying the range and magnitude of alcohol's harm to others in Australia. Addiction 2011; 106: 1603–1611.
    1. Navarro H. J., Doran C. M., Shakeshaft A. P. Measuring costs of alcohol harm to others: a review of the literature. Drug Alcohol Depend 2011; 114: 87–99.
    1. Laslett A., Waleewong O., Obot I., Benegal V., Hettige S., Florenzano R. et al. Scoping response system management of alcohol's harm to others in lower middle income countries. Nord Stud Alcohol Drugs 2016; 33: 515–536.
    1. Thanh N. X., Jonsson E. Life expectancy of people with fetal alcohol syndrome. J Popul Ther Clin Pharmacol 2016; 23: e53–9.
    1. Damashek A., Williams N. A., Sher K., Peterson L. Relation of caregiver alcohol use to unintentional childhood injury. J Pediatr Psychol 2009; 34: 344–353.
    1. Winqvist S., Jokelainen J., Luukinen H., Hillbom M. Parental alcohol misuse is a powerful predictor for the risk of traumatic brain injury in childhood. Brain Inj 2007; 21: 1079–1085.
    1. Quinlan K., Shults R. A., Rudd R. A. Child passenger deaths involving alcohol‐impaired drivers. Pediatrics 2014; 133: 966–972.
    1. World Health Organization . Global Status Report on Road Safety 2015. Geneva, Switzerland: World Health Organization; 2015.
    1. Bushman B., Cooper H. Effects of alcohol on human aggression: an integrative research review. Psychol Bull 1990; 107: 341–354.
    1. Graham K., West P. Alcohol and Crime In: Heather N., Peters T. J., Stockwell T., editors. International Handbook of Alcohol Dependence and Problems. London: John Wiley & Sons; 2001, pp. 439–470.
    1. Abbey A., Clinton‐Sherrod A. M., McAuslan P., Zawacki T., Buck P. O. The relationship between the quantity of alcohol consumed and the severity of sexual assaults committed by college men. J Interpers Violence 2003; 18: 813–833.
    1. Clausen T., Martinez P., Towers A., Greenfield T., Kowal P. Alcohol consumption at any level increases risk of injury caused by others: data from the study on Global Ageing and adult health. Subst Abuse Res Treat 2016; 9: 125–132.
    1. Hull J. G., Bond C. F. J. Social and behavioral consequences of alcohol consumption and expectancy: a meta‐analysis. Psychol Bull 1986; 99: 347–360.
    1. Ito T. A., Miller N., Pollock V. E. Alcohol and aggression: a meta‐analysis on the moderating effects of inhibitory cues, triggering events, and self‐focused attention. Psychol Bull 1996; 120: 60–82.
    1. Room R., Rossow I. The share of violence attributable to drinking. J Subst Use 2001; 6: 218–228.
    1. Shield K. D., Rylett M. J., Gmel G., Rehm J. Part 1. Trends in alcohol consumption and alcohol‐attributable mortality in the EU in 2010 In: World Health Organization Regional Office for Europe , editor. Status Report on Alcohol and Health in 35 European Countries 2013. Copenhagen: WHO Regional Office for Europe; 2013, pp. 3–14.
    1. Shkolnikov V. M., Nemtsov A. V. The anti‐alcohol campaign and variations in Russian mortality In: Bobadilla J. L., Costello C. A., Mitchell F., editors. Premature Death in the New Independent States. Washington, DC: National Academy Press; 1997, pp. 239–261.
    1. Rehm J. Measuring quantity, frequency and volume of drinking. Alcohol Clin Exp Res 1998; 22: 4S–14S.
    1. Shaper A., Wannamethee G., Walker M. Alcohol and mortality in British men: explaining the U‐shaped curve. Lancet 1988; 2: 1267–1273.
    1. Rehm J. Alcohol consumption and mortality. What do we know and where should we go? Addiction 2000; 95: 989–995.
    1. Chen X., Zhou L., Zhang Y., Yi D., Liu L., Rao W. et al. Risk factors of stroke in Western and Asian countries: a systematic review and meta‐analysis of prospective cohort studies. BMC Public Health 2014; 14: 776.
    1. McKenzie K., Harrison J. E., McClure R. J. Identification of alcohol involvement in injury‐related hospitalisations using routine data compared to medical record review. Aust J Public Health 2010; 34: 146–152.
    1. Saunders J. B., Room R. Enhancing the ICD system in recording alcohol's involvement uin disease and injury. Alcohol Alcohol 2012; 47: 216–218.
    1. Klingemann H., Gmel G. Mapping Social Consequences of Alcohol Consumption. Dordrecht, the Netherlands: Kluwer Academic Publishers; 2001.
    1. Institute of Health Metrics and Evaluation . GBD 2015 Codebook, Institute of Health Metrics and Evaluation. 2015. Available at: /Web (accessed 25 October 2016) (Archived at ).
    1. Patra J., Jha P., Rehm J., Suraweera W. Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self‐reported symptoms of active tuberculosis: individual participant data (IPD) meta‐analyses of 72,684 individuals in 14 high tuberculosis burden countries. PLoS One 2014; 9: E96433.
    1. Traphagen N., Tian Z., Allen‐Gipson D. Chronic ethanol exposure: pathogenesis of pulmonary disease and dysfunction. Biomolecules 2015; 5: 2840–2853.
    1. Simet S. M., Sisson J. H. Alcohol's effects on lung health and immunity. Alcohol Res 2015; 37: 199–208.
    1. Foulds J. A., Adamson S. J., Boden J. M., Williman J. A., Mulder R. T. Depression in patients with alcohol use disorders: systematic review and meta‐analysis of outcomes for independent and substance‐induced disorders. J Affect Disord 2015; 1: 47–59.
    1. Bartolomei F. Epilepsy and alcohol. Epileptic Disord 2006; 8: S72–8.
    1. Puddey I. B., Beilin L. J. Alcohol is bad for blood pressure. Clin Exp Pharmacol Physiol 2006; 33: 847–852.
    1. Xin X., He J., Frontini M. G., Ogden L. G., Motsamai O. J., Whelton P. K. Effects of alcohol reduction on blood pressure: a meta‐analysis of randomized controlled trials. Hypertension 2001; 38: 1112–1117.
    1. Roerecke M., Kaczorowski M., Tobe S. W., Gmel G., Hasan O. S. M., Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta‐analysis of trial data. Lancet Public Health 2017; in press.
    1. Chen L., Smith G. D., Harbord R. M., Lewis S. J. Alcohol intake and blood pressure: a systematic review implementing a Mendelian Randomization Approach. PLoS Med 2008; 5: 461–471.
    1. Mukamal K. J., Rimm E. B. Alcohol's effects on the risk for coronary heart disease. Alcohol Res Health 2001; 25: 255–261.
    1. Roerecke M., Rehm J. Ischemic heart disease mortality and morbidity in former drinkers: a meta‐analysis. Am J Epidemiol 2011; 173: 245–258.
    1. George A., Figueredo V. M. Alcoholic cardiomyopathy: a review. J Card Fail 2011; 17: 844–849.
    1. Manthey J., Imtiaz S., Neufeld J., Rylett M., Rehm J. Quantifying the Global Contribution of Alcohol Consumption to Cardiomyopathy. Toronto, ON, Canada: 2017.
    1. Rosenqvist M. Alcohol and cardiac arrhythmias. Alcohol Clin Exp Res 1998; 22: 318s–322s.
    1. Rosenberg M. A., Mukamal K. J. The estimated risk of atrial fibrillation related to alcohol consumption. J Atr Fibrillation 2012; 5: 83–92.
    1. Samokhvalov A. V., Irving H. M., Rehm J. Alcohol as a risk factor for atrial fibrillation: a systematic review and meta‐analysis. Eur J Cardiovasc Prev Rehabil 2010; 17: 706–712.
    1. Larsson S. C., Drca N., Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose–response meta‐analysis. J Am Coll Cardiol 2014; 64: 281–289.
    1. Murray C. J. L., Lopez A. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269–1276.
    1. Mazzaglia G., Britton R., Altmann D. R., Chenet L. Exploring the relationship between alcohol consumption and non‐fatal or fatal stroke: a systematic review. Addiction 2001; 96: 1743–1756.
    1. Reynolds K., Lewis B., Nolen J., Kinney G., Sathya B., He J. Alcohol consumption and risk of stroke: a meta‐analysis. JAMA 2003; 289: 579–588.
    1. Patra J., Taylor B., Irving H., Roerecke M., Baliunas D., Mohapatra S. et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types—a systematic review and meta‐analysis. BMC Public Health 2010; 10: 258.
    1. Zhang C., Qin Y. Y., Chen Q., Jiang H., Chen X. Z., Xu C. L. et al. Alcohol intake and risk of stroke: a dose–response meta‐analysis of prospective studies. Int J Cardiol 2014; 174: 669–677.
    1. Tseng M., Everhart J. E., Sandler R. S. Dietary intake and gallbladder disease: a review. Public Health Nutr 1999; 2: 161–172.
    1. Shabanzadeh D. M., Sørensen L. T., Jørgensen T. Determinants for gallstone formation—a new data cohort study and a systematic review with meta‐analysis. Scand J Gastroenterol 2016; 51: 1239–1248.
    1. Farkas A., Kemény L. Psoriasis and alcohol: is cutaneous ethanol one of the missing links? Br J Dermatol 2010; 162: 771–716.
    1. Brenaut E., Horreau C., Pouplard C., Barnetche T., Paul C., Richard M. A. et al. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27: 30–35.
    1. Richard M. A., Barnetche T., Horreau C., Brenaut E., Pouplard C., Aractingi S. et al. Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence‐based recommendations based on systematic review and expert opinion. J Eur Acad Dermatol Venereol 2013; 27: 2–11.
    1. Zhu K. J., Zhu C. Y., Fan Y. M. Alcohol consumption and psoriatic risk: a meta‐analysis of case–control studies. J Dermatol 2012; 39: 770–773.
    1. Adamzik K., McAleer M. A., Kirby B. Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol 2013; 38: 819–822.
    1. Poikolainen K., Karvonen J., Pukkala E. Excess mortality related to alcohol and smoking among hospital‐treated patients with psoriasis. Arch Dermatol 1999; 135: 1490–1493.
    1. Patra J., Bakker R., Irving H., Jaddoe V. W. V., Malini S., Rehm J. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses. Int J Obstet Gynaecol 2011; 118: 1411–1421.
    1. Global Burden of Disease Study . Global Burden of Disease Study 2015. Causes of death and Nonfatal Causes Mapped to ICD codes. Seattle, WA: Institute for Health Metrics and Evaluation; 2016.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する